November 13, 2006 May 15, 2020 Subjects : Clarification of Operating Performance for the Q1/2020 Attention : The Director and Manager of the Stock Exchange of Thailand The Consolidated net profit of
11 August 2017 approving the reviewed consolidated financial statements for Quarter 2 of 2016 ending on 30 June 2017, the Company would like to report factors that affect the financial performance for
Company”) held on 7 November 2017, approving the reviewed consolidated financial statements for 3rd Quarter of 2017 ending on 30 September 2017, the Company and its subsidiaries would like to report factors
(“Company”) would like to notify the operating result stated in consolidated financial statements for the second Quarter period ended June 30, 2020 compared with the same period of 2019. For the operating
-Balance-Sheet Management The Company disclosed in Note 22 of the financial statements and consolidated financial report as of 31st December 2018 was summarized below. • During the past year, there were no
consolidated comprehensive financial statement. Loss Attributable to Equity Holders of the Company In this captioned quarter, the loss attributable to equity holders of the company was Baht 10.80 million whereas
: pato1@cscoms.com August 11, 2017 President The Stock Exchange of Thailand The consolidated financial statement of Pato Chemical Industry Plc. and its subsidiary for Q2 ended June 30, 2017 operational
ZIGA Innovation Public Company Limited ("the Company") would like to clarify operating performance of the Company three-month for the Quarter 2/2017 and consolidated financial statements ended 30th June
(“Company”) would like to notify the operating result stated in consolidated financial statements for the third Quarter period ended September 30, 2020 compared with the same period of 2019. For the operating
equivalent to 2.91 times due to lower inventory. Liability and Off-Balance-Sheet Management The Company disclosed in Note 23 of the financial statements and consolidated financial report as of 31st December